Published in Hospital and Nursing Home Week, February 15th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Nymox Pharmaceutical.
Report 1: Nymox Pharmaceutical Corporation (NYMX) announced financial results for the third quarter of 2006 with a net loss of $1,238,833, or $0.04 per share for the quarter, compared to $958,464, or $0.04 per share for same period in 2005.
The increase in the net loss is attributable to stock-based compensation costs ($282,063 compared to $4,055 for the same period in 2005) and to an increase in research and development expenditures (15% increase...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.